The global sales of MRI-compatible IV infusion pump systems are estimated to be worth USD 308.2 million in 2025 and anticipated to reach a value of USD 763.9 million by 2035. Sales are projected to rise at a CAGR of 9.5% over the forecast period between 2025 and 2035. The revenue generated by MRI-compatible IV infusion pump systems in 2024 was USD 281.5 million.
Rising cases of chronic diseases, including cancer, neurological conditions, and cardiovascular diseases, is one of the primary factors behind the growing demand for MRI-compatible IV infusion pump systems.
In most chronic illnesses, diagnosis by imaging tests such as MRI is a must in follow-up disease management and to monitor the treatment effects. Due to the requirement for high-resolution non-invasive images without using ionizing radiation, MRI is very crucial in chronic illness management.
Many patients undergoing MRI need continuous intravenous (IV) medication, which may include sedatives, pain relievers, or contrast agents, for adequate imaging and comfort.
Global MRI-Compatible IV Infusion Pump Systems Industry Outlook
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 281.5 million |
| Estimated Size, 2025 | USD 308.2 million |
| Projected Size, 2035 | USD 763.9 million |
| Value-based CAGR (2025 to 2035) | 9.5% |
The strong magnetic fields present in MRI environments make traditional IV infusion pumps unsuitable, and they are known to create safety risks. MRI-compatible IV infusion pumps solve this critical challenge because they are specifically designed to work safely and efficiently in magnetic fields of up to 3T or higher, allowing uninterrupted therapy during imaging.
Moreover, the increasing prevalence of chronic diseases has led to a higher volume of MRI procedures, which further fuels the demand for advanced solutions such as MRI-compatible infusion pumps. These systems not only improve patient safety and comfort but also enhance workflow efficiency in MRI suites by eliminating the need to reposition or remove patients from the scanner for medication administration.
The increasing chronic diseases worldwide coupled with the increasingly accepted use of MRI as a tool for both diagnostic and follow-up purposes, this is creating strong demand for MRI-compatible IV infusion pumps.
These can be driven forward by other forms of advancements; these could relate to enhancing precision, improving use, or perhaps even offering safe features and other factors to integrate them more directly into today's diagnostic imaging setup.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The below table presents the expected CAGR for the global MRI-compatible IV infusion pump systems market over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2024 to 2035, the business is predicted to surge at a CAGR of 5.8%, followed by a slightly lower growth rate of 5.5% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.8% (2024 to 2035) |
| H2 | 5.5% (2024 to 2035) |
| H1 | 5.1% (2025 to 2035) |
| H2 | 4.6% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 5.1% in the first half and decrease moderately at 4.6% in the second half. In the first half (H1) the market witnessed a decrease of 70.00 BPS while in the second half (H2), the market witnessed an increase of 90.00 BPS.
Technological Advancements in Material Science Have Revolutionized the Design of MRI-Compatible IV Infusion Pumps
Technological advances in material science have revolutionized the design of MRI-compatible IV infusion pumps through enhanced magnetic shielding and non-magnetic components. Such innovations are becoming a critical driver for the market because they solve unique challenges related to high-magnetic-field environments within MRI scanners, such as 1.5T and 3T systems. Traditional infusion pumps are unsuitable for such settings because magnetic interference can lead to device malfunctions, inaccurate drug delivery, and potential patient safety risks.
The infusion pumps are MRI compatible because they incorporate advanced magnetic shielding materials, like specialized alloys and high-strength polymers, ensuring that the infusion pumps are not affected by the strong magnetic fields. Moreover, the use of non-magnetic components in areas such as motors and sensors makes them more MRI compatible. Such improvements have minimized the risk of electromagnetic interference significantly, thus making infusion therapy run smoothly and accurately during imaging procedures.
The development is not only related to meeting one of the basic safety requirements but also the enlargement of the field of application for infusion pumps with advanced diagnostic imaging. Due to their reliability, MRI-compatible pumps are now considered indispensable by imaging facilities. Consequently, increased demands for high-field MRI scanners lead to faster acceleration in infusion pumps with magnetic shielding and nonmagnetic designs to expand the market.
The Growing Utilization of MRI-compatible IV Infusion Pumps in Standalone Diagnostic Imaging Centers Is a Significant Driver for The Market.
Diagnostic imaging centers are gaining preference from patients and health care providers as specialized centers providing imaging services. These centers typically have to manage high volumes of MRI procedures every day. Hospitals, on the other hand, focus solely on providing health care services. Such specialized service requires sophisticated equipment for accuracy, safety, and efficient functioning. Thus, MRI-compatible IV infusion pumps become a must in diagnostic imaging centers.
The requirement of continuous intravenous drug administration - contrast agents, sedatives or essential medications given during MRI procedure - has obliged these centers to invest in specialized pumps compatible with MRI. Being designed to perform safely in such high-magnetic-field environments ensures uninterrupted drug delivery and minimizes risks associated with traditional pumps through electromagnetic interference and malfunction.
Another reason their role as critical end-users is increasing rapidly with the growing trend of outsourcing the diagnostic services to standalone centers. Hospitals and clinics refer many patients to these standalone centers for the advanced imaging modalities like MRI scans, creating a need for high-performing equipment like MRI-compatible infusion pumps.
As diagnostic imaging centers continue to increase their services in terms of meeting a rising demand for MRI procedures, the adoption of MRI-compatible IV infusion pumps is expected to rise, further fueling expansion and technological advancements in this market.
Enhanced Magnetic Shielding Technology Is a Key Driver in The Growth of The MRI-Compatible IV Infusion Pump Systems Market
Enhanced magnetic shielding technology is a more significant market driving force for MRI-Compatible IV infusion pump systems against the challenges offered by high-magnetic-field environments: 1.5T and 3T in MRI scanners, where traditional infusion pumps might not be tolerated because of such strong magnetic fields that could produce malfunctions on the device level, disrupt drugs delivery, or compromise patient safety.
The innovations in material science have recently given birth to new high-end magnetic shielding solutions and non-magnetic components. With these, infusion pumps can safely and reliably be used in MRI suites without causing electromagnetic interference. High-strength polymers, non-magnetic materials, and special alloys used in components like motors and sensors ensure that the pumps function without being influenced by the magnetic fields of MRI systems.
The growth in research for higher-field MRI systems, like 5T MRI scanners, is likely to increase the demand for infusion pumps that are more resistant to stronger magnetic fields. The advancement toward 5T MRI scanners, which can provide better imaging, will increase the need for better magnetic shielding to make infusion pumps operate safely in advanced environments.
The development of these advanced technologies not only ensures uninterrupted drug delivery during MRI scans but also improves patient safety and operational efficiency. As the adoption of high-field MRI systems continues to rise, especially with the growing research into 5T scanners, the demand for MRI-compatible infusion pumps will continue to fuel the growth of the market.
High Cost of MRI-Compatible IV Infusion Pumps Is Emerging as Significant Growth Barrier for Phlebotomy Equipment Market.
One major obstacle that is limiting the growth of the MRI-Compatible IV infusion pump systems market is the high cost of MRI-compatible IV infusion pumps. These specialized pumps are devised for safe operation within the high-magnetic-field environment of MRI scanners and thus require the use of advanced components such as magnetic shielding materials, non-magnetic motors, and sensors. The incorporation of these materials along with strict safety protocols to prevent electromagnetic interference leads to more expensive costs compared to standard infusion pumps.
The average cost of an MRI-compatible IV infusion pump can go from USD 5,000 to USD 10,000, with variations according to brand and features. On the other hand, a standard, non-MRI-compatible IV infusion pump might cost between USD 1,000 and USD 3,000. That cost difference is so large because of the extra engineering, specialized materials, and testing that go into making the pump work with an MRI.
With significant front-end costs associated with these pumps, it remains a significant deterring factor especially for smaller hospitals, outpatient clinics, and limited budget diagnostic centers. Facilities based in regions with significantly lower healthcare budget or those having larger volumes might avoid purchasing them as they would defer the purchase decision until the need and demand are relatively higher, so that they are forced to be dependent on old pumps or administer drugs manually under MRI.
This cost barrier can limit the widespread adoption of MRI-compatible infusion pumps, especially in emerging markets or lower-income healthcare settings, thus hindering market growth and access to advanced medical technologies.
The global MRI-compatible IV infusion pump systems industry recorded a CAGR of 5.5% during the historical period between 2020 and 2024. The growth of MRI-compatible IV infusion pump systems industry was positive as it reached a value of USD 281.5 million in 2024 from USD 209.6 million in 2020.
The overall strategy of the MRI-Compatible IV infusion pump systems market is toward meeting the increased demand for safe, uninterrupted intravenous drug delivery during MRI procedures. The market has seen drastic changes over time, influenced by the development of material science, magnetic shielding technology, and increasingly complex MRI systems, including 1.5T and 3T MRI scanners.
Initially, MRI-compatible pumps was a niche market but nowadays, because of the increasing requirements for high-quality diagnostics and continuous infusion during imaging, these systems appear to be a critical component in modern healthcare setups.
Several future market trends include connectivity and IoT-enabled systems for long-distance monitoring that could ensure efficacy as well as safety in patient care. Moreover, the latest designs are all miniaturized and portable, therefore increasing integration in compact MRI suites. The continuous research into higher-field MRI scanners, like the 5T MRI system, will drive the demand for more advanced infusion pumps to enable exposure to stronger magnetic fields.
Furthermore, advances in AI-based predictive maintenance and data analytics will help the management of pumps. This will minimize downtime and improve infusion therapy. With more health care facilities focusing on superior patient care and efficient operations, these trends are also likely to propel market growth in the near future.
Tier 1 companies comprise market leaders with a significant market share of 26.1% in global market. These companies engage in strategic partnerships and acquisitions to expand their product portfolios and access cutting-edge technologies.
Additionally, they emphasize extensive clinical trials to validate the efficacy and safety of their products. Prominent companies in tier 1 include Becton, Dickinson Company (Carefusion), Baxter International Inc. and B.Braun Melsungen AG.
Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market and holds around 33.5% market share. They typically pursue partnerships with academic institutions and research organizations to leverage emerging technologies and expedite product development.
These companies often emphasize agility and adaptability, allowing them to quickly bring new treatments to market, additionally targeting specific types medical conditions. Additionally, they focus on cost-effective production methods to offer competitive pricing. Prominent companies in tier 2 include iRadimed Corporation and Fresenius Kabi AG.
Finally, Tier 3 companies, such as Smiths Medical (Smiths Group plc.) and Arcomed AG Inc. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the MRI-compatible IV infusion pump systems sales remains dynamic and competitive.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the industry analysis for the market for MRI-compatible IV infusion pump systems for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle Ease & Africa, is provided. The United States is anticipated to remain at the forefront in North America, with higher market share through 2035. In South Asia & Pacific, India is projected to witness a CAGR of 7.4% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 3.3% |
| Germany | 4.2% |
| France | 3.5% |
| Spain | 4.1% |
| China | 6.2% |
| India | 7.4% |
| Australia & New Zealand | 5.6% |
| South Korea | 5.0% |
United States. MRI-compatible IV infusion pump systems market is poised to exhibit a CAGR of 3.3% between 2025 and 2035. Currently, it holds the highest share in the North American market.
The presence of significant medical device manufacturers such as Medtronic, Baxter, and Smiths Medical results in added advantages when it comes to innovation,
manufacturing, and distributing MRI-compatible infusion pumps. These players are well-positioned for uniquely tailoring high-quality, state-of-the-art medical devices, remaining capable of MR semiclassical infusion pump development.
The important manufacturing capacity of these players enables large-scale manufacturing of MRI-compatible pumps, thus sustaining their management of the ever-growing demands from hospitals, outpatient clinics, and diagnostic imaging centers. These companies also have well-established distribution networks throughout the USA, ensuring the quick delivery of supplies to providers. Continuously pouring new investments into research and development promotes uninterrupted improvements in MRI-compatible infusion pump technology and keeps the USA market at the forefront of all innovations.
China’s market for MRI-compatible IV infusion pump systems is poised to exhibit a CAGR of 6.2% between 2025 and 2035. Currently, it holds the highest share in the East Asia market, and the trend is expected to continue during the forecast period.
China has become a global manufacturing center for medical devices, especially using its sophisticated production capabilities, low-cost manufacturing processes, and large-scale production capacity. This allows the Chinese manufacturer to offer MRI-compatible infusion pumps at competitive prices and make them appealing to both domestic and international healthcare facilities.
Chinese companies are now aggressively going to emerging markets in Southeast Asia, Africa, and Latin America. There is increased healthcare infrastructure in these areas and rapid medical equipment needs. Several places in these regions are cost-constrained and prefer lower costs. Affordability and accessibility of MRI-compatible pumps from China make them a go-to choice. Therefore, Chinese manufacturers are increasing their market share globally and making China a major exporter of medical devices. This is contributing to the rapid growth of the MRI-compatible infusion pump market in the world.
India’s market for MRI-compatible IV infusion pump systems is poised to exhibit a CAGR of 7.4% between 2025 and 2035. Currently, it holds the highest share in the South Asia & Pacific market, and the trend is expected to continue during the forecast period.
The private health sectors have led the diagnostic imaging sector as a highly lucrative business, hospitals, freestanding imaging centers, and diagnostic chains catering for the healthcare needs of the majority of the population. Many of these players are spending more on sophisticated technologies like MRI-compatible IV infusion pumps to scale up quality of care to keep patients in need of precision and interrupted care within and after MRI procedures.
Many of these chains are also opening new branches all over tier 2 and tier 3 cities owing to increasing healthcare awareness and demand for high-end diagnostics in such neglected regions. Another trend empowering the private healthcare sector-emerging that is the segment of rising expectations from patients towards high-quality care; the overall compatibility of market growth within India amidst this has been amplified.
The section contains information about the leading segments in the industry. By product type, the non-magnetic MRI-compatible IV infusion pumps segment holds the highest market share of 63.4% in 2025.
| By Product Type | Non-Magnetic MRI-Compatible IV Infusion Pumps |
|---|---|
| Value Share (2025) | 63.4% |
These pumps are made from materials that entirely avoid magnetic interference, thereby becoming well-suited for safe application in such standard MRI settings. Their reliability, cost-effectiveness, and capability of meeting the routine imaging procedure are the very reasons that account for their higher demand.
Manufacturers are likewise focusing on improving their performances and designs to cope with the widening scope of demand. Moreover, their market position is further reinforced by the increased availability of non-magnetic IV infusion pumps compatible with the majority of MRI scanners.
Non-magnetic MRI-compatible IV infusion pumps are leading the market because these safety and reliability-based features are increasingly drawing the attention of healthcare practitioners in light of the global move toward affordable yet safe solutions, therefore, becoming integral to modern diagnostic and therapeutic practices.
Affordable non-magnetic infusion pumps have gained popularity in hospitals and diagnostic centers at the expense of their magnetic counterpart. Therefore, they offer a practical alternative for small- and large-scale healthcare providers.
In addition, the growing number of installations of MRI in developing regions, where cost limitations are significant, contributes further to the market share of non-magnetic infusion pumps.
| By End User | Hospitals |
|---|---|
| Value Share (2025) | 24.9% |
The market for MRI-compatible IV infusion pump systems end-user segment consists primarily of hospitals due to their role in providing advanced diagnostic and therapeutic services. As most MRI is performed in the hospitals, other hospitals are geared toward critically ill patients needing continuous intravenous (IV) medication shifts while undergoing imaging. In this context, MRI-compatible IV infusion pumps become essential items for controlled and uninterrupted drug delivery in high magnetic field areas in hospitals.
It is likely that hospitals prioritize, as well as develop, multi-specialty hospitals that feature integrated diagnostic imaging facilities. These high-cost establishments deal with patients suffering from serious health problems like cancer, cases of neurological disorders, and conditions of cardiovascular diseases; therefore, the number of MRI procedures will always be high, as will the demand for compatible infusion systems.
Another major driver for this. The growing trend of multi-specialty hospitals with integrated diagnostic imaging facilities is that hospitals are expected to remain the leading end-user segment in this market. With the rise of chronic diseases and MRI utilization, this is possible.
The market players are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in MRI-Compatible IV Infusion Pump Systems Market
In terms of product type, the industry is divided into- non-magnetic MRI-compatible IV infusion pumps and magnetic-resistant MRI-compatible IV infusion pumps.
In terms of application, the industry is segregated into- neurological disorders, oncology, cardiovascular disorders, orthopedic applications and others.
In terms of end user, the industry is segregated into- hospitals, diagnostic imaging centers, ambulatory surgical centers (ASCs) and specialty clinics.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
The global market for MRI-compatible IV infusion pump systems is projected to witness CAGR of 9.5% between 2025 and 2035.
The global MRI-compatible IV infusion pump systems industry stood at USD 281.5 million in 2024.
The global market for MRI-compatible IV infusion pump systems is anticipated to reach USD 763.9 million by 2035 end.
India is set to record the highest CAGR of 7.4% in the assessment period.
The key players operating in the global market for MRI-compatible IV infusion pump systems include Becton, Dickinson Company (Carefusion), Baxter International Inc., B.Braun Melsungen AG, iRadimed Corporation, Fresenius Kabi AG, Smiths Medical (Smiths Group plc.) and Arcomed AG.
| Estimated Size, 2024 | USD 2,861.0 million |
|---|---|
| Projected Size, 2034 | USD 5,436.8 million |
| Value-based CAGR (2024 to 2034) | 6.6% |
| Estimated Size, 2024 | USD 4,949.0 million |
|---|---|
| Projected Size, 2034 | USD 8,832.8 million |
| Value-based CAGR (2024 to 2034) | 5.9% |
| Market Value (2022) | USD 3,851.4 million |
|---|---|
| Market Value (2032) | USD 5,958.6 million |
| Market Projected Growth Rate (2022 to 2032) | 4% |
| Market Value 2022 | USD 910.9 Million |
|---|---|
| Market Value 2029 | USD 1.23 Billion |
| CAGR 2022 to 2029 | 4.4% |
Explore Therapeutic Device Insights
View Reports
MRI-Compatible IV Infusion Pump Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
